Covid Pills
-
{
- All
- News
-
Chinese Cat Owners Are Feeding Covid-19 Pills To Their Pets. Here's Why
Merck & Co.'s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as antidotes to a life-threatening disease caused by a coronavirus that infects their feline companions.
-
Indian-American Ex-Pfizer Employee Charged With Insider Trading On Covid Pill
Indian-American former Pfizer Inc. employee, Amit Dagar, who was charged with insider trading and a conspiracy to commit insider trading last year, has been convicted by the US Attorney for the Southern District of New York.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
105 Nations To Get Cheaper Merck Covid Pill
Generic drug manufacturers will make a more affordable version of Merck's anti-Covid pill for 105 of the world's poorer nations, a UN-backed organisation said on Thursday.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Merck's Covid Pill Not In India's Treatment Plan, Has Major Safety Concerns
India has not added Merck's pill to the list of treatments for Covid due to 'major safety concerns', a top health official said today.
-
Joe Biden Doubles US Purchase Of Pfizer Covid Pills As Cases Surge
President Joe Biden announced Tuesday a doubling of US government purchases of new Pfizer therapeutic pills designed to combat the worst effects of Covid-19.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
The Covid Pill For India: What We Know
Dr. D Srinivasa Reddy, CMD, Optimus Pharma Private Limited, spoke to NDTV today to explain the basics of the recently-cleared Covid pill for India. Molnupiravir has been licensed by US pharma giant Merck for over a dozen Indian firms.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
-
Second Covid Pill Cleared By US Today, (First Pfizer, Now Merck)
The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults, a day after a similar pill by Pfizer was given the green light.
-
Chinese Cat Owners Are Feeding Covid-19 Pills To Their Pets. Here's Why
Merck & Co.'s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as antidotes to a life-threatening disease caused by a coronavirus that infects their feline companions.
-
Indian-American Ex-Pfizer Employee Charged With Insider Trading On Covid Pill
Indian-American former Pfizer Inc. employee, Amit Dagar, who was charged with insider trading and a conspiracy to commit insider trading last year, has been convicted by the US Attorney for the Southern District of New York.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
105 Nations To Get Cheaper Merck Covid Pill
Generic drug manufacturers will make a more affordable version of Merck's anti-Covid pill for 105 of the world's poorer nations, a UN-backed organisation said on Thursday.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Merck's Covid Pill Not In India's Treatment Plan, Has Major Safety Concerns
India has not added Merck's pill to the list of treatments for Covid due to 'major safety concerns', a top health official said today.
-
Joe Biden Doubles US Purchase Of Pfizer Covid Pills As Cases Surge
President Joe Biden announced Tuesday a doubling of US government purchases of new Pfizer therapeutic pills designed to combat the worst effects of Covid-19.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
The Covid Pill For India: What We Know
Dr. D Srinivasa Reddy, CMD, Optimus Pharma Private Limited, spoke to NDTV today to explain the basics of the recently-cleared Covid pill for India. Molnupiravir has been licensed by US pharma giant Merck for over a dozen Indian firms.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
-
Second Covid Pill Cleared By US Today, (First Pfizer, Now Merck)
The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults, a day after a similar pill by Pfizer was given the green light.
